Science by press release: Moderna cashes in on mRNA cancer vaccine without publishing trial results
"These corporations have learned how to play the medical-scientific establishment like a Stradivarius," Johns Hopkins cardiology operations chief says after Moderna share price spikes. Its mRNA flu vaccine trial data are still hidden.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.